Skip to Main Content


New Jersey Expands Access to Hepatitis C Medications for Patients on Medicaid

By | Leave a Comment

A proposed rule change would allow patients afflicted with Hepatitis C access to medications prior to exhibiting fibrosis or liver damage. In addition, $ 10 million were allocated to expand Medicaid Hep C services beginning fiscal year 2019, which begins in July.

This is in line with overall efforts of Gov. Phil Murphy to expand coverage for the state’s vulnerable residents which includes $ 4.3 billion in state funding for Medicaid.

For more information, see:

Thematic Areas:

Comments are closed.

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.